Gilead Sciences, Inc. (GILD)
149.59
-1.81
(-1.20%)
USD |
NASDAQ |
Feb 23, 15:17
Gilead Sciences EPS Diluted (Quarterly) : 1.74 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.183B |
| Revenue (Quarterly) | 7.925B |
| Total Expenses (Quarterly) | 5.742B |
| Enterprise Value | 177.23B |
| Gross Profit Margin (Quarterly) | 86.84% |
| Profit Margin (Quarterly) | 27.55% |
| Earnings Yield | 4.53% |
| Operating Earnings Yield | 6.28% |